Bank Of Montreal Ocugen, Inc. Transaction History

Bank Of Montreal

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Jun 13, 2024	BUY	$0.82 - $1.33 $9,576 - $15,533	11,679 New	11,679 $9,000
Q4 2022 Feb 01, 2023	BUY	$1.11 - $1.87 $6,607 - $11,132	5,953 New	5,953 $7,000
Q2 2022 Aug 11, 2022	BUY	$1.83 - $3.45 $301 - $569	165 Added 2.87%	5,917 $15,000
Q1 2022 May 12, 2022	BUY	$2.34 - $4.72 $13,459 - $27,149	5,752 New	5,752 $20,000

124

78.3M

535K

523K

Ticker OCGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,566,000
Market Cap $167M
Description
Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

Stay updated on Bank Of Montreal with notifications on news.